People · Operator
Named in public records as an officer, director or promoter · active 2020–2021 · Investment Vehicle, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| FCA Venture Partners VII QP, LP | — | Investment Vehicle | Series C | $60.3M | $847.9M | 2021 |
| FCA Health Innovations II QP, LP | — | Healthtech | Series C | $55.1M | $1.3B | 2020 |
| FCA Venture Partners VII, LP | — | Investment Vehicle | Series A | $8.8M | $98.3M | 2021 |
| FCA Health Innovations II, LP | — | Healthtech | Series A | $8.5M | $167.9M | 2020 |
Andrew J Bouldin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew J Bouldin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matthew A> King | 4 | 14 |
| Nancy S. Allen | 4 | 7 |
| JOHN R. BURCH, JR. | 4 | 7 |
| James A Patton | 4 | 5 |
| Whitney L Haley | 4 | 4 |
| Thomas K. Hearn III | 2 | 4 |
| Whitney L Kalb | 2 | 2 |
| Whitney H Kalb | 2 | 2 |
| Charles (Todd) W Johnson | 2 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.